ClinicalTrials.gg
Not yet recruitingNCT07943832BE-PreparedUpdated Nov 17, 2026

Blended Eclectic Programme to Improve Community Preparedness for Acute Myocardial Infarction

An interventional study of Blended Eclectic programme for optimising community Preparedness (BE-Prepared) and Usual Care in Coronary Artery Disease, Acute Myocardial Infarction (AMI) and Care-seeking, sponsored by The University of Hong Kong. Not yet recruiting at 3 sites in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Prevention

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
438
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 10 studies in Coronary Artery Disease by The University of Hong Kong — 3 open to participants now, 4 under way, none of them phase 3. Coronary Artery Disease · The University of Hong Kong.

Started
2027
the only one that year
No phase
5 of 10
3 open now
Registered
10th of 10
by date

Among the 10 studies in Coronary Artery Disease by The University of Hong Kong, this one is the only one that started in 2027, is one of 5 with no phase, and was the 10th registered.

Coronary Artery Disease

4,863 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.

Browse Coronary Artery Disease studies →

Open to participants now

3 of the 10 studies in Coronary Artery Disease by The University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 588 Coronary Artery Disease studies recruiting now, 402 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 38 take children under 18; 48 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Coronary Artery Disease by The University of Hong Kong, or all of them as a file.
02

Study summary

Coronary artery disease (CAD) is the leading cause of death and disability worldwide, and acute myocardial infarction (AMI, commonly known as heart attack) is its most severe and life-threatening form. In a heart attack, the time from symptoms onset to the receipt of reperfusion therapy to restore blood flow ("total ischaemic time") strongly influences how much heart muscle is saved and whether the patient survives. The longer the delay, the worse the outcome.

Despite effort to reduce in-hospital delay through establishment of chest pain centres, a critical gap remains. The time taken by patients to recognise symptoms and seek care during the prehospital stage accounts for the largest proportion of total ischaemic time. This study proposes the "Blended Eclectic Programme for Optimising Community Preparedness (BE-Prepared)" to improve timely care-seeking behaviours among CAD patients and the general public, ultimately reducing prehospital delays and improving AMI patient outcomes in Hong Kong. This programme consists of two components: a community-based health education component and a narrative intervention for CAD patients.

It is hypothesised that CAD patients who receive the BE-Prepared programme, compared with those receiving usual care, will show greater improvements in behavioural intention to seek care for AMI symptoms, better AMI knowledge, and fewer perceived barriers to care-seeking. It is further hypothesised that CAD patients who receive the programme will report a shorter onset-to-door time, be more likely to use an ambulance, and have reduced in-hospital stays and fewer 30-day major adverse cardiac and cerebrovascular events following an AMI episode relative to the control group.

The study uses a type 2 effectiveness-implementation hybrid design, combining a randomised controlled trial with a qualitative study to evaluate both whether the programme works and how it can be integrated into routine practice. Adults aged ≥18 with confirmed CAD but no prior AMI will be recruited from three major Hong Kong public hospitals and randomly assigned 1:1 to BE-Prepared or usual care. Outcomes will be assessed at baseline, 3 months, and 12 months, with 12-month monitoring for acute coronary events, guided by the RE-AIM framework. Healthcare providers will join SWOT workshops and selected patients will be interviewed. If effective, BE-Prepared could close a critical gap in current services, reducing prehospital delay and improving AMI outcomes in Hong Kong.

Read the detailed description

Acute myocardial infarction (AMI) is a highly time-sensitive emergency in which treatment delay is associated with larger infarct size, more complications, and higher mortality. A key prognostic determinant is total ischaemic time, the interval from symptom onset to reperfusion therapy. Although clinical guidelines recommend a system delay of under 60 minutes from diagnosis to wire crossing during primary percutaneous coronary intervention, and Hong Kong is establishing chest pain centres (CPCs) from July 2025 to reduce in-hospital delays, the prehospital interval remains the largest contributor to total ischaemic time.

Care-seeking is a complex perceptual-cognitive process requiring accurate symptom attribution, perceived susceptibility to a life-threatening event, and the influence of contextual factors such as competing responsibilities and external prompts. Therefore, this study proposes a comprehensive, theory-driven approach-the Blended Eclectic programme for optimising community Preparedness (BE-Prepared)-to improve timely care-seeking behaviours among CAD patients and the general public.

The study adopts a type 2 effectiveness-implementation hybrid design, simultaneously assessing clinical effectiveness and implementation with equal priority. It comprises a prospective, assessor-blinded, two-arm randomised controlled trial (RCT) to evaluate the effects of the BE-Prepared programme among CAD patients, and a qualitative study to gather stakeholder insights on the implementation process. Following written informed consent, participants will be randomly allocated in a 1:1 ratio to the intervention group (BE-Prepared programme) or the control group (usual care). The BE-Prepared programme consists of two components: a community-based health education component and a narrative intervention for CAD patients. Allocation will be concealed. A research assistant will ask participants to select a sealed envelope corresponding to a computer-generated random number, assigning them to the intervention or control group.

CAD participants will be recruited from three major public hospitals providing emergency cardiac care. Recruitment will be publicised through social media and the patient self-help organisation. Eligible participants will receive a verbal explanation supplemented by an information sheet and must sign an informed consent form prior to data collection, receiving a signed copy. A baseline assessment lasting approximately 30 minutes will be scheduled. Healthcare providers for the SWOT analysis will be recruited from cardiac wards at three major hospitals and will attend a 1.5-hour SWOT workshop to identify barriers and facilitators to integrating BE-Prepared into routine CAD care. The sample size was calculated based on prior findings from a theory-based narrative intervention developed by the project team for AMI survivors, in which effect sizes for attitudes and beliefs regarding care-seeking were 0.34 and 0.41 at 12 months post-intervention. Using PASS 2021, 175 participants per arm provide 80% power at a 5% two-sided significance level to detect an effect size of 0.30. Allowing for a 20% dropout rate, 438 participants will be recruited (219 per group) for the two-arm RCT, together with 45 healthcare professionals for the SWOT analysis across the participating hospitals.

Descriptive statistics will summarise reach, adoption, and maintenance data. Baseline homogeneity between study groups will be assessed using the independent t-test, chi-square test, or Fisher's exact test as appropriate. Generalised estimating equations (GEE) will compare changes in outcome variables across T0, T1, and T2 between groups, accounting for intra-correlated repeated measures and accommodating randomly missing data due to incomplete attendance or dropout. Between-group differences in symptom onset-to-door (O2D) time and ambulance use among participants experiencing an AMI by T2 will be assessed using the independent t-test and chi-square test. A generalised linear model with an appropriate link function will compare major adverse cardiovascular and cerebrovascular event (MACCE) episodes, hospital readmissions, and length of stay. Analyses will follow an intention-to-treat approach; all tests will be two-sided with p \< 0.05 considered statistically significant, conducted in IBM SPSS 29.0. Qualitative interview data will be audio-recorded, transcribed verbatim, and cross-checked against the original recordings by the lead principal investigator. Content analysis will code participants' perceptions, engagement experience, and the acceptability of the intervention, and will explore how and why the programme influences care-seeking behaviours and intentions. To enhance trustworthiness, an audit trail will be maintained and two investigators will independently code the qualitative data.

03

Conditions studied

  • Coronary Artery Disease
  • Acute Myocardial Infarction (AMI)
  • Care-seeking

Keywords

  • coronary artery disease
  • acute myocardial infarction
  • care-seeking behaviour
  • cardiac patients
  • health education
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

For participants for the BE-Prepared programme

Inclusion Criteria:

  • Adults with age ≥18 years
  • Residing in the community
  • Confirmed CAD diagnosis
  • Without a prior history of AMI; and
  • Access to an internet-enabled device

Exclusion Criteria:

  • Individuals who do not understand Cantonese
  • Individuals who have impaired communication, psychiatric problems or cognitive impairment (i.e., Abbreviated Mental Test ≤6)

For health providers participating in the SWOT analysis

Inclusion Criteria:

  • Full-time staff (doctors, nurses and social workers) in the Cardiac department of the study hospital who involve in providing care to cardiac patients

Exclusion Criteria:

  • Health care providers with part-time employment
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
438 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Participants will receive usual care, access to the community-based health education initiative, and the five-week blended narrative intervention comprising one face-to-face workshop followed by four weekly web-based modules with nurse-facilitated interactive sessions.

    Behavioral: Blended Eclectic programme for optimising community Preparedness (BE-Prepared)

  • Active comparator
    Control group

    Participants will receive usual care, comprising unstructured health education provided by the healthcare team, and access to the community-based health education initiative. They will not receive the structured five-week narrative intervention.

    Other: Usual Care

Interventions

  • BehavioralBlended Eclectic programme for optimising community Preparedness (BE-Prepared)

    The BE-Prepared programme consist of 2 components: a community-based health education initiative and a five week narrative intervention. 1. The community-based health education component will utilise multiple media platforms, including Facebook, Instagram and YouTube, to provide AMI education to the general public with interactive and multimedia features incorporated. Regular online health seminars in live-streaming format will be held twice per quarter, featuring expert speakers in cardiovascular health-related topics. 2. The narrative intervention will be delivered via a blended format, including a face-to-face workshop followed by four weekly web-based sessions that include pre-recorded educational materials and real-time interactions. Each module will be structured in two parts: first, a series of pre-recorded 3-5 minutes videos that introduce key information, and second, a real-time interactive session led by a nurse facilitator that consolidates learning.

  • OtherUsual Care

    The usual care includes unstructured health education provided by the healthcare team and access to the community-based health education component of this project.

06

What researchers measure

Primary outcomes

  1. Care-seeking attitudes and beliefs for AMI symptoms, measured by the Acute Coronary Syndrome Response Index (ACSRI)

    The Acute Coronary Syndrome Response Index-Chinese version (ACSRI-C) will be used to assess patients' attitudes and knowledge regarding AMI care-seeking. The ACSRI has good reliability (Cronbach's alphas: 0.76-0.82) and discriminant validity. It consists of a total of 33 questions divided into 3 scales measuring knowledge, attitudes, and belief. The attitudes subscale consists of 5 items, while the beliefs subscale consists of 7 items. Participants respond on a 4-point Likert scale. The higher subscale total scores (range for the attitudes subscale, 5-20; range for the beliefs subscale, 7-28) indicate more appropriate care-seeking attitudes and beliefs.

    Time frame: At baseline (T0), 3 months (T1) and 12 months (T2) post-programme

Secondary outcomes

  1. Knowledge of AMI symptoms

    AMI knowledge was measured using the knowledge subscale of the ACSRI-C. This subscale consists of 21 items to be answered dichotomously (yes/no). The correct items are summed (range, 0-21), and a higher total score represents greater knowledge

    Time frame: At baseline (T0), 3 months (T1) and 12 months (T2) post-programme

  2. Perceived barriers to care-seeking, measured by the 10-item Perceived Barriers to Health Care-seeking Decision (PBHSD) scale

    The 10-item Perceived Barriers to Health Care-seeking Decision (PBHSD) will be used to measure perceived barriers to care-seeking when patients experience AMI symptoms. Each item is rated on a 6-point Likert scalewith"1" indicating strongly disagree and "6" indicating strongly agree. The sum of scores on each item gives the overall score. The possible range of scores is 10-60, with higher scores indicating greater perceived barriers to seeking care.

    Time frame: At baseline (T0), 3 months (T1) and 12 months (T2) post-programme

  3. Symptom onset-to-door (O2D) time among participants experiencing an AMI episode

    O2D time, defined as the interval between the onset of ischaemic symptoms and hospital arrival will be determined through patient recall, using a benchmarking technique that associates symptom onset with daily routines to improve recall accuracy. The hospital arrival times will be verified from medical records.

    Time frame: 12 months following enrolment

  4. Ambulance use for transport to hospital among participants experiencing an AMI episode

    The proportion of participants who used emergency ambulance services (versus other transport modes) to reach hospital during an AMI episode will be collected from reviewing medical records.

    Time frame: 12 months following enrolment

  5. In-hospital and 30-day major adverse cardiovascular and cerebrovascular events (MACCEs)

    In-hospital and 30-day MACCEs, including cardiac- and non-cardiac-related mortality, malignant arrhythmias, recurrent AMI, unplanned coronary interventions or surgeries, new onset heart failure, and stroke, will be extracted from medical records according to the Standardized Data Collection for Cardiovascular Trials Initiative guidelines.

    Time frame: 12 months following enrolment

  6. Length of hospital stay among participants experiencing an AMI episode

    Total length of the index hospital stay (in days) following an AMI episode, will be collected from reviewing medical records.

    Time frame: 12 months following enrolment

  7. Unplanned 30-day hospital readmissions among participants experiencing an AMI episode

    The unplanned hospital readmissions within 30 days of discharge following an AMI episode, will be collected from reviewing medical records.

    Time frame: 12 months following enrolment

Other outcomes

  1. Reach of the BE-Prepared programme

    The reach of the target population will be assessed by recording the number of eligible participants and those who participate in the BE-Prepared programme.

    Time frame: Through study completion, 3 years since commencement

  2. Adoption and engagement with the BE-Prepared programme

    Adoption will be assessed by documented attendance at the face-to-face session and the real-time online sessions. User engagement with programme materials will be tracked by the number of video views, the number of responses to embedded quizzes, and the average frequency and duration of viewing the programme materials.

    Time frame: Over the 5-week intervention delivery period

  3. Implementation of the BE-Prepared programme

    The implementation of the programme will be evaluated through assessing the adherence to the intended delivery protocol by two independent reviewers against a fidelity checklist, qualitative interviews with 30 participants and a self-developed 10-item participant satisfaction survey.

    Time frame: Over the 5-week intervention delivery period and upon completion

07

Study locations

3 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Feb 2029, 25 months later.

Of 754 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's planned 25 months is below that.

Counting every sponsor, half of 931 studies reached it within 30 months; a quarter within 15 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 17, 2026
StartEst.
Jan 2027
Primary completionEst.
Feb 2029
CompletionEst.
Feb 2029
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943832
Responsible party
Dr. Polly Wai-Chi Li (Associate Professor, Principal Investigator, The University of Hong Kong) — Principal investigator
First posted
Nov 17, 2026
Start date
Jan 2027 (estimated)
Primary completion
Feb 2029 (estimated)
Completion
Feb 2029 (estimated)
Last update
Nov 17, 2026

Study contacts

Dr. Polly Wai-Chi Li, PhD
Contact
pwcli@hku.hk
+852 39176686
Polly Wai Chi Li, PhD
principal investigator · The University of Hong Kong, School of Nursing

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion